• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC DECANAV; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC DECANAV; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING Back to Search Results
Catalog Number R7F282CT
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Cardiac Tamponade (2226)
Date of Event 05/27/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
D4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.The bwi product analysis lab received the device for evaluation 18-mar-2026.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.The manufacturer's reference number: (b)(4).
 
Event or Problem Description
It was reported that a patient underwent a supraventricular tachycardia (svt) ablation with a decanav catheter and the patient experienced a pericardial effusion that required a pericardiocentesis.They noticed the effusion when they went in with intracardiac echocardiography (ice) when considering going transseptal.Ice was the only method used to confirm the effusion.A pericardiocentesis was performed on the patient, and 400 ml was drained.The patient's last known status was stable.No ablation was done and there was no generator in use.Biosense webster inc.Products in the body at the time were a soundstar® catheter and a decanav catheter.Additional information was received.Transseptal puncture was not performed during the procedure.The patient did not require extended hospitalization because of the adverse event.Patient fully recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DECANAV
Common Device Name
CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
Precision Concepts Costa Rica
saret industrial park building
rio segundo
alajuela 90109
CS   90109
Manufacturer Contact
henry boden
31 technology dr
irvine, CA 92618
9497882078
MDR Report Key25626999
Report Number3013300026-2026-02006
Device Sequence Number15699178
Product Code DRF
UDI-Device Identifier10846835008807
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K080425
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Type of Report Initial,Followup
Report Date (Section B) 09/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberR7F282CT
Device Lot NumberAD26030008
Date Returned to Manufacturer06/24/2026
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/27/2026
Supplement Date Received by Manufacturer08/26/2026
Initial Report FDA Received Date06/25/2026
Supplement Report FDA Received Date09/23/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/02/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Life Threatening;
Patient SexFemale
Patient RaceWhite
-
-